Compliance certificate as per regulation 74(5) of SEBI (DP) Regulations, 2018.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Bharat Parenterals Limited has submitted a quarterly compliance certificate to BSE under SEBI's Regulation 74(5). The certificate was issued by the company's Registrar and Share Transfer Agent, Adroit Corporate Services Private Limited, for the quarter ended December 31, 2025. It confirms that all securities received from depository participants for dematerialization during the quarter were properly confirmed to the depositories. The RTA also confirms that physical share certificates received for demat were mutilated and cancelled after due verification, and the depository's name was substituted as the registered owner in the company's member register within the 15-day deadline. The filing is signed by Sharmin Soni, the Company's Company Secretary & Compliance Officer. No material business or financial information is disclosed in this filing.
This is a routine procedural compliance filing with no material impact on the company's financials, operations, or share price. It simply fulfills a standard regulatory requirement confirming that share dematerialization activities were handled correctly during the October–December 2025 quarter.